Protagen Launches GMP Protein Analysis Services
News Apr 25, 2007
Protagen AG has been awarded Good Manufacturing Practice (GMP) certification and has announced that it will be providing customers with protein analysis services in accordance with the international quality assurance guidelines with immediate effect.
Protagen is one of the first biotechnology companies in Germany to meet the requirements for approval from the USA Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) to offer analytical methods within the guidelines for manufacturers of therapeutic proteins.
Commenting on the announcement, Christoph Huels, CEO of Protagen said: "Being awarded GMP certification is a great achievement for Protagen and underlines our strategy to provide protein analysis services of the highest quality. We are committed to supporting our customers in their effort to meet the industry's increasingly strict controls and regulations, and we are delighted to be able to offer the flexibility of tailoring research programmes and providing protein services under GMP where required."
Protagen became certified for protein analysis under GMP in May 2006. Since that time, the Company’s GMP-compliant protein analysis services have been tested with numerous reference customers.
Protagen has recently completed a programme of work under GMP for Nordmark Pharma, Hamburg and will now introduce the GMP services to a wider circle of pharmaceutical customers.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018